Investor profile
Mid-Atlantic Bio Angels (MABA)
None, US
What they invest in
Mid-Atlantic Bio Angels (MABA) is an exclusive angel investor group focusing on new and emerging life science companies. Their investment thesis centers around biotechnology, bioinformatics, biopharma, diagnostics, therapeutics, and medical devices. They typically invest in early-stage startups, with a check size ranging from 1 to 5 million dollars per company. Geographically, they do not have specific preferences. Some of their previous investments include companies like Astrocyte Pharmaceuticals and Hilltop BioSciences. MABA seeks partnerships with companies that have a strong, commercially-minded management team, offer solutions that change the standard of care significantly, operate in regulated markets with large potential exits, and require funding below $10 million per round, totaling about $30 million or less before exit.
Stages
Regions
Cheque size
Who works there
We hold nobody at Mid-Atlantic Bio Angels (MABA) yet. That costs you nothing, and we add people as soon as we can verify them.
Are you Mid-Atlantic Bio Angels (MABA)? Correct this entry or ask us to remove it.